SEP 23, 2020 11:30 AM PDT

Break-out: Setting Yourself Up for Core Success - A panel discussion

Speakers

Abstract

Suspension by day, imaging by night: how to efficiently manage your system and optimize utilization

Presented By: Jared K. Burks, PhD

Mass cytometry, be it suspension or imaging, opens the doors to a large user base. How can one efficiently utilize the system for the greatest research impact and support for your facility? How hard is it to switch between suspension and imaging modes? How does one support the reagent needs of both options?

 

Comparing fluorescent flow and mass cytometry optimization and implementation workflows

Presented By: Matthew Cochran, MS

The URMC FCR sought to compare both mass and fluorescent flow cytometry in practical terms such as time (preparation of sample and acquisition), cell recovery and cost of experiments to help guide our user base in choosing which technique was best for their needs. As a case study we partnered with the LungMAP project to help them achieve their goal of maximizing the information learned from precious lung samples. In this presentation we will quickly review this case study and the outcomes and future directions of this work.

 

High-throughput mass cytometry in a clinical research setting

Presented By: Emily Thrash, PhD

Biomarker discovery in clinical cancer research is limited by the inherent complexity of the disease and the immune response, as well as a lack of validated immune-phenotyping methodology. With the capability to measure up to 50 parameters from a single cell, mass cytometry using CyTOF® is well-poised to overcome these constraints and provide greater breadth and depth to cellular phenotyping. In a clinical setting, with large sample numbers collected at different timepoints, reduction of technical variability and in-depth analysis of cellular immune response is critical. By combining reference sample spike-in and palladium-based mass tag cell barcoding sample, our group has optimized a high-throughput workflow for generating reproducible and consistent CyTOF data. In our lab, we routinely use this workflow to comprehensively analyze activation, exhaustion, memory and trafficking cellular phenotypes in the peripheral immune system of cancer patients receiving therapy, and to detect biomarker candidates.

 

Engaging with pathologists on IMC projects: keys to success

Presented By: Akil Merchant, MD


Show Resources
You May Also Like
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
Loading Comments...
Show Resources
Attendees